DealsKKR’s Gamma Biosciences to sell Astrea Bioseparations to BiotageGamma's sale of Astrea will be in exchange for newly issued shares in Biotage.ByIrien Joseph15 February 2023•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcareTMTTop Stories